Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder.
Hao Zhang, PhD
Advertisement
Articles by Hao Zhang, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
4
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
5